Source: International Congress 2017 – Infection and exacerbation science
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Martucci (PARMA, PR, Italy). Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation. 995

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection Source: International Congress 2016 – Immune responses in the lung Year: 2016 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Role of CD163 in human fatal asthma and murine asthma model. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 The prevention of virus-induced exacerbation of bronchial asthma in children Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Investigation of the very early immune response in viral induced experimental asthma exacerbation Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Murine model for investigating virus-induced exacerbations of COPD-related inflammation – preclinical biomarker validation Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation Source: ERS Lung Science Conference 2019 Year: 2019